Charles River Laboratories vs Lonza Cell & Gene Technologies

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/criver/lonza

Category	Charles River Laboratories	Lonza Cell & Gene Technologies
Listed site	both	cdmo
Summary	Charles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years.	Lonza is the world's leading CDMO, founded in Switzerland in 1897, serving the healthcare industry with integrated offerings for contract development and manufacturing of therapies across multiple modalities.
Services	CMC Regulatory Submission Support Quality Control Testing Technology Transfer Formulation Development Process Development Cell Therapy Manufacturing Viral Vector Manufacturing Recombinant Protein Manufacturing Monoclonal Antibody (mAb) Manufacturing Biologics Development & Manufacturing API Synthesis & Manufacturing Upstream Processing Downstream Processing CMC Analytical Development Stability Testing & Storage Cell-Line Development Microbial Fermentation Small Molecule Development & Manufacturing AAV Manufacturing Lentiviral Vector Manufacturing Sterile Fill-Finish & Aseptic Manufacturing	Cell-Line Development Protein Engineering Analytical Method Development & Validation Process Development Formulation Development Technology Transfer Recombinant Protein Manufacturing Monoclonal Antibody (mAb) Manufacturing Biologics Development & Manufacturing API Synthesis & Manufacturing Small Molecule Development & Manufacturing Regulatory Affairs Cell Therapy Manufacturing Upstream Processing Downstream Processing Quality Control Testing Microbiology Services Translational Research CMC Analytical Development Stability Testing & Storage
Modalities	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Cell Therapy Gene Therapy AAV / Viral Vector Platform	Biologics (Monoclonal Antibodies) Biologics (Other) Cell Therapy Gene Therapy
Indications	Oncology Immunology Neurology	Data not yet provided.
Locations	Headquarters, United States North America, North America, USA/Canada Europe, Europe, Multiple Asia, Asia, Multiple North America, North America Europe, Europe Asia, Asia	Headquarters, Basel, Basel-Stadt, Switzerland
Certifications	FDA · Identifier: 100 IND submissions containing Retrogenix® platform data EMA · Identifier: 100 IND submissions containing Retrogenix® platform data PMDA · Identifier: 100 IND submissions containing Retrogenix® platform data EMA · Identifier: Retrogenix® platform data support PMDA · Identifier: Retrogenix® platform data support	Data not yet provided.
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.